-
Mashup Score: 0
Dr. Morava-Kozicz of the Mayo Clinic explain how the RDCRN Consortium, FCDGC, has improves our understanding of congenital disorders of glycosylation.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
Dr. Morava-Kozicz of the Mayo Clinic explain how the RDCRN Consortium, FCDGC, has improves our understanding of congenital disorders of glycosylation.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Dr. Morava-Kozicz of the Mayo Clinic explain how the RDCRN Consortium, FCDGC, has improves our understanding of congenital disorders of glycosylation.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Dr. Morava-Kozicz of the Mayo Clinic explain how the RDCRN Consortium, FCDGC, has improves our understanding of congenital disorders of glycosylation.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
Dr. Morava-Kozicz of the Mayo Clinic explain how the RDCRN Consortium, FCDGC, has improves our understanding of congenital disorders of glycosylation.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2
Dr. Morava-Kozicz of the Mayo Clinic explain how the RDCRN Consortium, FCDGC, has improves our understanding of congenital disorders of glycosylation.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Eva Morava-Kozicz, MD, PhD of the Mayo Clinic in Rochester, MN profiles an overview of congenital disorders of glycosylation (CDG). https://t.co/CixIMenoUj @EvaMorava @MayoClinic @NIH @rarediseasesnet @FrontierCDG @worldCDG @UK_CDG #raredisease #MayoClinicRochesterMinnesota